![]()
MIRA INFORM
REPORT
|
Report Date : |
26.04.2011 |
IDENTIFICATION DETAILS
|
Name : |
AL KENANA FOR IMPORT AND EXPORT |
|
|
|
|
Registered Office : |
3 Hussain Saad
Street, Giza, Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2010 |
|
|
|
|
Year of Establishment : |
1994 |
|
|
|
|
Com. Reg. No.: |
33274 |
|
|
|
|
Legal Form : |
General Partnership |
|
|
|
|
Line of Business : |
Import and distribution of pharmaceuticals, drugs, veterinary products and animal feed additives |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 125,000 |
|
Status : |
Satisfactory |
|
Payment
Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2010
|
Country Name |
Previous Rating (30.09.2010) |
Current Rating (31.12.2010) |
|
Egypt |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company Name : AL KENANA FOR IMPORT AND EXPORT
Country of Origin : Egypt
Legal Form : General Partnership
Registration Date : 1994
Commercial Registration Number : 33274
Partners Capital : £E 75,000
Total Workforce : 15
Activities :
Import and distribution of pharmaceuticals, drugs,
veterinary products
and animal feed additives
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
Recommended Credit Limit : US$ 125,000
AL KENANA FOR IMPORT AND EXPORT
Street : 3 Hussain Saad Street
Area : Giza
Town : Cairo
Country : Egypt
Telephone : (20-2) 33778354
Facsimile : (20-2) 33778353
Mobile : (20-10) 2777418
Email : ahmed@kenavet.com
Subject operates
from a small suite of offices that are rented and located in the Central
Business Area of Cairo.
Name Position
·
Dr Sayed El Badawi Abdulrahman Mohamed Managing
Partner
·
Dr
Ahmed Sayed El Badawi Abdulrahman Mohamed Partner
·
Khaled
Sayed El Badawi Abdulrahman Mohamed Partner
Date of Establishment : 1994
Legal Form :
General Partnership
Commercial Reg. No. : 33274
Partners Capital : £E 75,000
·
Dr Sayed El Badawi Abdulrahman Mohamed
·
Dr
Ahmed Sayed El Badawi Abdulrahman Mohamed
·
Khaled
Sayed El Badawi Abdulrahman Mohamed
Activities: Engaged in the import
and distribution of pharmaceuticals, drugs, veterinary products and animal feed
additives.
Import
Countries: India
International
Suppliers:
·
BVS India
·
Cidla India
·
Toni-Bio France
·
Xvet
GmbH Germany
·
MFI Tunisia
·
Ben
Sedon Yemen
·
El Nasr
Pharmaceuticals Egypt
Operating Trend: Steady
Subject has a
workforce of 15 employees.
Financial
highlights provided by local sources are given below:
Currency: Egyptian
Pound (£E)
Year
Ending 31/12/09: Year
Ending 31/12/10:
Total Sales £E 10,800,000 £E 11,350,000
Local sources
consider subject’s financial condition to be Fair.
The above financial
figures are based on estimations by our local sources.
·
National
Bank of Egypt
24 Sherif Street
Cairo
Tel: (20-2) 33924175
Fax: (20-2) 33924143
No complaints
regarding subject’s payments have been reported.
During the course
of this investigation nothing detrimental was uncovered regarding subject’s
operating history or the manner in which payments are fulfilled. As such the
business is considered to be a fair trade risk and the above credit figure is
within subject’s financial means.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.45 |
|
|
1 |
Rs.73.35 |
|
Euro |
1 |
Rs.64.78 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this report.
The assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.